The Relationship Between Acetylcholinesterase, Neurotransmitter Levels, Calcium, Vitamin D3, and Trace Minerals in Autism Spectrum Disorder

Ako Kaky; Sayran Saleh

doi:10.47419/bjbabs.v6i01.331

Authors

Ako Saber Kaky University of Kirkuk, Department of Chemistry, College of Science, Kirkuk, Iraq https://orcid.org/0000-0001-8720-6914
Sayran Sattar Saleh University of Kirkuk, Department of Chemistry, College of Science, Kirkuk, Iraq https://orcid.org/0000-0003-0783-9143

DOI:

https://doi.org/10.47419/bjbabs.v6i01.331

Keywords:

Acetylcholinesterase, Autism, Calcemia, Serum Calcium , Trace Mineral

Abstract

This study aimed to investigate the potential associations between acetylcholinesterase (AChE) activity, neurotransmitters, trace minerals, and autism spectrum disorder (ASD). A comparative analysis was conducted between 96 ASD patients and 96 healthy controls. Results revealed significantly lower AChE activity and specific activity in ASD patients compared to controls, corroborating previous findings linking AChE with neurological disorders. Furthermore, GABA and GRIA1 levels were elevated in ASD patients, while oxytocin and HDAC-2 were decreased. Notably, calcium and vitamin D levels were significantly lower in the ASD group, while magnesium and zinc levels were increased. Copper levels showed a decrease in ASD patients. Correlation analysis indicated significant negative correlations between AChE activity and oxytocin, and positive correlations between AChE activity and vitamin D, GABA, and zinc. These findings suggest potential dysregulations in the cholinergic, GABAergic, glutamatergic, and oxytocinergic systems, as well as imbalances in trace minerals, which may contribute to the pathophysiology of ASD. Further research is warranted to elucidate the underlying mechanisms and explore potential therapeutic interventions targeting these biochemical markers

Metrics

Metrics Loading ...

Downloads

Download data is not yet available.

References

Huang Q, Liao C, Ge F, Ao J, Liu T. Acetylcholine bidirectionally regulates learning and memory. Journal of Neurorestoratology. 2022;10(2):100002–100002. 10.1016/j.jnrt.2022.100002.

Zhao H, Mao X, Zhu C, Zou X, Peng F, Yang W, et al. GABAergic System Dysfunc- tion in Autism Spectrum Disorders. Front Cell Dev Biol . 2022;9:781327–781327. 10.3389/fcell.2021.781327.

Nisar S, Bhat AA, Masoodi T, Hashem S, Akhtar S, Ali TA, et al. Genetics of glutamate and its receptors in autism spectrum disorder. molecular psychiatry . 2022;27:2380– 2392. 10.1038/s41380-022-01506-w.

Baker E, Stavropoulos KK. The effects of oxytocin administration on individu- als with ASD: Neuroimaging and behavioral evidence. Prog Mol Biol Transl Sci . 2020;173:209–238. 10.1016/bs.pmbts.2020.04.009.

Botturi A, Ciappolino V, Delvecchio G, Boscutti A, Viscardi B, Brambilla P. The Role and the Effect of Magnesium in Mental Disorders: A Systematic Review. Nutrients. 2020;12(6):1661–1661. 10.3390/nu12061661.

Shayganfard M. Are Essential Trace Elements Effective in Modulation of Men- tal Disorders? Update and Perspectives. Biological Trace Element Research. 2022;200(3):1032–1059. 10.1007/s12011-021-02733-y.

Sauer AK, Hagmeyer S, Grabrucker AM. Prenatal Zinc Deficient Mice as a Model for Autism Spectrum Disorders. International Journal of Molecular Sciences. 2022;23(11):6082–6082. 10.3390/ijms23116082.

Usui N, Doi M, Berto S, Matsuoka K, Ishida R, Irie K, et al. Copper- deficiency is associated with impairments in social behavior and oligodendrocyte development via mTOR signaling pathway. medRxiv. 2023;p. 2023–2035. 10.1101/2023.12.16.23300061.

Park J, Lee K, Kim K, Yi SJ. The role of histone modifications: from neurodevel- opment to neurodiseases. Signal Transduction and Targeted Therapy . 2022;7(217). 10.1038/s41392-022-01078-9.

Singh S, Tiwari RK, Pandey RS. Acute toxicity evaluation of triazophos, deltamethrin and their combination on earthworm, Eudrilus eugeniae and its impact on AChE activity. Chemistry and ecology. 2019;35(6):563–575. 10.1080/02757540.2019.1600679.

Junior A, De Jesus EJ, Borges PC. Whey Protein Analysis Using the Lowry Assay and 96-Well-Plate Digital Images Acquired Using Smartphones. Journal of Chemical Education. 2023;100(6):2329–2338. 10.1021/acs.jchemed.2c00830.

Alrehaili AA, Gharib AF, Karam RA, Alhakami RA, Sawy WHE, Elrahman TMA. Clinical significance of plasma MMP-2 and MMP-9 levels as biomarkers for tumor expression in breast cancer patients in Egypt. Molecular Biology Reports. 2020;47(2):1153–1160. 10.1007/s11033-019-05216-5.

Nishiyama T, Sulistyaningdyah WT, Ueda K, Kusakabe H. GABA enzymatic assay kit. Bioscience, Biotechnology, and Biochemistry. 2020;84(1):118–125. 10.1080/09168451.2019.1661768.

Gnanadesikan GE, Hammock EA, Tecot SR, Carter CS, Maclean EL. Specificity of plasma oxytocin immunoassays: A comparison of commercial assays and sample preparation techniques using oxytocin knockout and wildtype mice. Psychoneu- roendocrinology. 2021;132:105368–105368. 10.1016/j.psyneuen.2021.105368.

Alim MA, Grujic M, Ackerman PW, Kristiansson P, Eliasson P, Peterson M, et al. Glutamate triggers the expression of functional ionotropic and metabotropic gluta- mate receptors in mast cells. Cellular & molecular immunology. 2021;18:2383–2392. 10.1038/s41423-020-0421-z.

Tang Y, Lin YH, Ni HY, Dong J, Yuan HJ, Zhang Y, et al. Inhibiting Histone Deacety- lase 2 (HDAC 2) Promotes Functional Recovery From Stroke. Journal of the Amer- ican Heart Association. 2017;6(10):7236–7236. 10.1161/JAHA.117.007236.

Al-Dujaili AH, k Al-Hakeim H, Twayej AJ, Maes M. Total and ionized calcium and magnesium are significantly lowered in drug-naïve depressed patients: effects of antidepressants and associations with immune activation. Metab Brain Dis. 2019;34(5):1493–1503. 10.1007/s11011-019-00458-5.

Hua BL. Spectrophotometric determination of calcium, magnesium and inorganic phosphate in cerebrospinal fluid. University of Windsor Chemistry and Biochem- istry; 1983. Available from: https://scholar.uwindsor.ca/etd/3555.

Al-Hasan AS. Correlation between Zinc and Iron with Psoriatic Patientsin Al-Anbar Governorate. Annals of RSCB;25(4):3589–3597.

Padro CA, Farmer CA, Thurm A, Shebl FM, Ilieva J, Kalra S, et al. Serum and cere- brospinal fluid immune mediators in children with autistic disorder: a longitudinal study. Mol Autism. 2017;8(1). 10.1186/s13229-016-0115-7.

Sattar SS, Rifaat SE. Effects of ethanolic Moringa oleifera extract on melatonin, liver and kidney function tests in alloxan-induced diabetic rats. Indian Journal of Forensic Medicine & Toxicology. 2019;13(4):1015–1019. 10.1186/s13229-016-0115-7.

Liu S, Li Z, Yu B, Wang S, Shen Y, Cong H. Recent advances on protein sep- aration and purification methods. Advances in Colloid and Interface Science. 2020;284(102254):102254–102254. 10.1016/j.cis.2020.102254.

Bravo RKD, Angelia MRN, Uy LYC, Garcia RN, Torio MAO. Isolation, purification and characterization of the antibacterial, antihypertensive and antioxidative prop- erties of the bioactive peptides in the purified and proteolyzed major storage pro- tein of pigeon pea (Cajanus cajan) seeds. Food Chemistry: Molecular Sciences. 2022;4(30):100062–100062. 10.1016/j.fochms.2021.100062.

Alwahab RMA, Zainal IG. Measurement of Protein Oxidation Levels in Serum of Women with Pregnancy Complications. Egyptian Journal of Chemistry. 2021;64(11):6449–6455. 10.21608/ejchem.2021.72125.3685.

Yıldız S, Bilen Ç, Karakuş E. Purification and Characterization of Polyphenol Oxidase Enzyme from Damson Plum (Prunus insititia) by Spectrophotometrically. research square. 2021;p. 1–30. 10.21203/rs.3.rs-803684/v1.

Pant DR, Aryal B, Pun D, Sharma S, Joshi GP. Inhibition of α-amylase and α- glucosidase activities in vitro by extracts of selected medicinal plants. Biodiversitas: Journal of Biological Diversity. 2021;22(3). 10.13057/biodiv/d220314.

Kaur D, Behl T, Sehgal A, Singh S, Sharma N, Chigurupati S, et al. Decrypt- ing the potential role of α-lipoic acid in Alzheimer’s disease. Life Sciences. 2021;284(1):119899–119899. 10.1016/j.lfs.2021.119899.

Oki S, Toiyama Y, Okugawa Y, Shimura T, Okigami M, Yasuda H, et al. Clinical burden of preoperative albumin- globulin ratio in esophageal cancer patients. The American Journal of Surgery. 2017;214(5):891–898. 10.1016/j.amjsurg.2017.04.007.

Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Tsujii M, Futatsubashi M, et al. Reduced Acetylcholinesterase Activity in the Fusiform Gyrus in Adults With Autism Spectrum Disorders. Archives of general psychiatry. 2011;68(3):306–313. 10.1001/archgenpsychiatry.2011.4.

Al-Sadi R, Engers J, Haque M, King S, Al-Omari D, Ma TY. Matrix Metalloproteinase-9 (MMP-9) induced disruption of intestinal epithelial tight junc- tion barrier is mediated by NF-κB activation. PloS One. 2021;16(4). 10.1371/jour- nal.pone.0249544.

Lord JR, Mashayekhi F, Salehi Z. How matrix metalloproteinase (MMP)- 9 (rs3918242) polymorphism affects MMP-9 serum concentration and associates with autism spectrum disorders: A case-control study in Iranian population. Dev Psy- chopathol. 2021;34(3):882–888. 10.1017/S0954579420002102.

Purkayastha P, Malapati A, Yogeeswari P, Sriram D. A Review on GABA/Gluta- mate Pathway for Therapeutic Intervention of ASD and ADHD. Curr Med Chem . 2015;22(15):1850–1859. 10.2174/0929867322666150209152712.

Zhao H, Mao X, Zhu C, Zou X, Peng F, Yang W, et al. GABAergic Sys- tem Dysfunction in Autism Spectrum Disorders. Front Cell Dev Biol. 2021;9. 10.3389/fcell.2021.781327.

Soto D, Altafaj X, Sindreu C, Bayes A. Glutamate receptor mutations in psychi- atric and neurodevelopmental disorders. Communicative & Integrative Biology. 2014;7(1). 10.4161/cib.27887.

Pichugina YA, Maksimova IV, Berezovskaya MA, Afanaseva NA, Pichugin AB, Dmitrenko DV, et al. Salivary oxytocin in autistic patients and in patients with intel- lectual disability. Front Psychiatry. 2022;13. 10.3389/fpsyt.2022.969674.

Huang Y, Huang X, Ebstein RP, Yu R. Intranasal oxytocin in the treatment of autism spectrum disorders: A multilevel meta-analysis. Neurosci Biobehav Rev. 2021;122:18–27. 10.1016/j.neubiorev.2020.12.028.

Guan FJ, Peng QQ, l Wang L, Yan XB, Dong C, Jiang XH. Histone deacetylase-2 expression and activity in children with nephrotic syndrome with different gluco- corticoid response. Pediatric Nephrology . 2017;33:269–276. 10.1007/s00467-017- 3791-4.

Tseng C, Mcdougle CJ, Hooker JM, Zürcher NR. Epigenetics of Autism Spec- trum Disorder: Histone Deacetylases. Biol Psychiatry. 2022;91(11):922–933. 10.1016/j.biopsych.2021.11.021.

Goncharov NV, Belinskaia DA, Avdonin PV. Organophospate-Induced Pathology: Mechanisms of Development, Principles of Therapy and Features of Experimental Studies. J Evol Biochem Physiol. 2023;109(10):1349–1397. 10.31857/S0869813923100059.

Luo TY, Cai S, Qin ZX, Yang SC, Shu Y, Liu CX, et al. Basal Forebrain Cholinergic Activity Modulates Isoflurane and Propofol Anesthesia. Front Neurosci. 2020;14. 10.3389/fnins.2020.559077.

Reddi AS. Calcium, Phosphorus, and Magnesium Disorders and Kidney Stones. In: and others, editor. Absolute Nephrology Review. vol. 2022; 2024. p. 173–209. 10.1007/978-3-030-85958-93.

Wang Q, Kong Y, Wu DY, Liu JH, Jie W, You QL, et al. Impaired calcium signaling

in astrocytes modulates autism spectrum disorder-like behaviors in mice. nature communications . 2021;12(3321). 10.1038/s41467-021-23843-0.

Guo M, Li L, Zhang Q, Dai Y, Chen L, Liu L, et al. Vitamin and mineral status of chil- dren with autism spectrum disorder in Hainan Province of China: associations with symptoms. Nutr Neurosci . 2018;23(10):803–810. 10.1080/1028415X.2018.1558762.

Rihal V, Khan H, Kaur A, Singh TG, Abdel-Daim MM. Therapeutic and mech- anistic intervention of vitamin D in neuropsychiatric disorders. Psychiatry Res . 2022;317:114782–114782. 10.1016/j.psychres.2022.114782.

El-Hawy MA, Saleh NY. Effect of cyclic pamidronate administration on osteoporo- sis in children with β-thalassemia major: a single-center study. Clin Exp Pediatr. 2022;65(8):405–409. 10.3345/cep.2019.00535.

Ambelil M, Sultana S, Roy S, Gonzalez MM. Anaplastic Transformation in Mandibu- lar Metastases of Follicular Variant of Papillary Thyroid Carcinoma: A Case Report and Review of the Literature. Ann Clin Lab Sci. 2016;46(5):552–556.

Siracusano M, Riccioni A, Abate R, Benvenuto A, Curatolo P, Mazzone L. Vitamin D Deficiency and Autism Spectrum Disorder. Curr Pharm Des . 2022;26(21):2460– 2474. 10.2174/1381612826666200415174311.

Ersfeld DL, Rao DS, Body JJ, Sackrison JL, Miller AB, Parikh N, et al. Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem. 2004;37(10):867–874. 10.1016/j.clinbiochem.2004.06.006.

Guo M, Zhu J, Yang T, Lai X, Lei Y, Chen J, et al. Vitamin A and vitamin D deficiencies exacerbate symptoms in children with autism spectrum disorders. Nutr Neurosci . 2018;22(9):637–647. 10.1080/1028415X.2017.1423268.

Lee BK, Eyles DW, Magnusson C, Newschaffer CJ, McGrath JJ, Kvaskoff D, et al. Developmental vitamin D and autism spectrum disorders: findings from the Stock- holm Youth Cohort. Mol Psychiatry. 2021;26(5):1578–1588. 10.1038/s41380-019- 0578-y.

Mazahery H, Camargo CA, Conlon C, Beck KL, Kruger MC, v Hurst PR. Vitamin D and Autism Spectrum Disorder: A Literature Review. Nutrients. 2016;8(4):236–236. 10.3390/nu8040236.

Kardani A, Soltani A, Sewell R, Shahrani M, Rafieian-Kopaei M. Neuro- transmitter, Antioxidant and Anti-neuroinflammatory Mechanistic Potentials of Herbal Medicines in Ameliorating Autism Spectrum Disorder. Curr Pharm Des. 2019;25(41):4421–4429. 10.2174/1381612825666191112143940.

Skalny AV, Mazaletskaya AL, Ajsuvakova OP, Bjørklund G, Skalnaya MG, Cher- nova LN, et al. Magnesium Status in Children with Attention-Deficit/Hyperactivity Disorder and/or Autism Spectrum Disorder. Soa Chongsonyon Chongsin Uihak . 2020;31(1):41–45. 10.5765/jkacap.190036.

El-Meshad GM, El-Khair MSA, Moharam NM, El-Nabi SAA. The plasma zinc/serum copper ratio as a biomarker in children with autism spectrum disorders. Menoufia Medical Journal. 2017;30(3):727–733. 10.4103/1110-2098.218255.

Hawari I, Eskandar MB, Alzeer S. The Role of Lead, Manganese, and Zinc in Autism Spectrum Disorders (ASDs) and Attention-Deficient Hyperactivity Disor- der (ADHD): a Case-Control Study on Syrian Children Affected by the Syrian Crisis. Biol Trace Elem Res. 2020;197(1):107–114. 10.1007/s12011-020-02146-3.

Sarasamma S, Audira G, Juniardi S, Sampurna BP, Liang ST, Hao E, et al. Zinc Chlo- ride Exposure Inhibits Brain Acetylcholine Levels, Produces Neurotoxic Signatures, and Diminishes Memory and Motor Activities in Adult Zebrafish. Int J Mol Sci. 2018;19(10):3195–3195. 10.3390/ijms19103195.

Zieminska E, Ruszczynska A, Augustyniak J, Toczylowska B, Lazarewicz J. Zinc and Copper Brain Levels and Expression of Neurotransmitter Receptors in Two Rat ASD Models. Front Mol Neurosci. 2021;14. 10.3389/fnmol.2021.656740.

Li S, l Wang J, Bjørklund G, Zhao W, Yin C. Serum copper and zinc levels in individuals with autism spectrum disorders. Neuroreport . 2014;25(15):1216–1220. 10.1097/WNR.0000000000000251.